Status:
COMPLETED
Hepcidin in Anemic Chronic Heart Failure (CHF) Patients
Lead Sponsor:
Medical University of Vienna
Conditions:
Anemia
Chronic Heart Failure
Eligibility:
All Genders
18+ years
Brief Summary
Background: Anemia in chronic heart failure (CHF) is directly linked to increased mortality and reduced exercise capacity. The pathomechanism for the development of anemia in CHF is not well understoo...
Eligibility Criteria
Inclusion
- Systolic left ventricular dysfunction (LVEF\<45%)
- Signed informed consent
Exclusion
- Women of child bearing potential
- Pregnancy
- Non cardiac illness limiting life expectancy to \<1 year
- Renal disease of non-cardiac reason
- Malignancy
- Chronic inflammatory disease
- Acute infection
- Erythropoietin therapy or iron substitution within the last 6 months
Key Trial Info
Start Date :
January 1 2007
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2010
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT00437866
Start Date
January 1 2007
End Date
July 1 2010
Last Update
December 6 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Medical University of Vienna
Vienna, Vienna-Austria, Austria, 1090